Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunityTim Bognàr, Imke H. Bartelink, Tayfun Güngör et al.|Blood Advances|2024Cited by 13
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridgingEmilie P. Buddingh, Mary Slatter, Juan Carlos Aldave Becerra et al.|Journal of Human Immunity|2025Cited by 11